Jump to content
RemedySpot.com

GSK to drop IV version of Arzerra for injectable

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 10

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

GlaxoKline PLC and Genmab A/S will end the development of an intravenous

form of a drug intended to treat autoimmune diseases like lupus and multiple

sclerosis, and focus on an injectable version.

Arzerra is approved as a treatment for chronic lymphocytic leukemia in patients

who have received at least one previous therapy.

The companies are also testing it as a treatment for newly diagnosed chronic

lymphocytic leukemia, and lymphoma.

Source: http://www.businessweek.com/ap/financialnews/D9I91KPO2.htm

~chris

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...